Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2008
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidismGeoffrey A Block, Steven Zeig, Jared Sugihara, et al.
The American Journal of Clinical Nutrition|July 1, 2016
Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney diseaseCarly E Dougher, Dena E Rifkin, Cheryl Am Anderson, et al.
Kidney International|August 2, 2013
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patientsKevin J Martin, Karen Pickthorn, Saling Huang, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 29, 2011
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterolsGlenn M Chertow, Z John Lu, Xiao Xu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysisAreef Ishani, Jiannong Liu, James B Wetmore, et al.
American Journal of Nephrology|October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on HemodialysisDavid A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Journal of the American Society of Nephrology : JASN|February 5, 2017
Effect of Tenapanor on Serum Phosphate in Patients Receiving HemodialysisGeoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2020
Differential effects of phosphate binders on vitamin D metabolism in chronic kidney diseaseCharles Ginsberg, Leila R Zelnick, Geoffrey A Block, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2015
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomyJames B Wetmore, Jiannong Liu, Thy P Do, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
Coronary and aortic calcifications in patients new to dialysisDavid M Spiegel, Paolo Raggi, Ravindra Mehta, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2008
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidismGeoffrey A Block, Steven Zeig, Jared Sugihara, et al.
The American Journal of Clinical Nutrition|July 1, 2016
Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney diseaseCarly E Dougher, Dena E Rifkin, Cheryl Am Anderson, et al.
Kidney International|August 2, 2013
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patientsKevin J Martin, Karen Pickthorn, Saling Huang, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 29, 2011
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterolsGlenn M Chertow, Z John Lu, Xiao Xu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysisAreef Ishani, Jiannong Liu, James B Wetmore, et al.
American Journal of Nephrology|October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on HemodialysisDavid A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Journal of the American Society of Nephrology : JASN|February 5, 2017
Effect of Tenapanor on Serum Phosphate in Patients Receiving HemodialysisGeoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2020
Differential effects of phosphate binders on vitamin D metabolism in chronic kidney diseaseCharles Ginsberg, Leila R Zelnick, Geoffrey A Block, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2015
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomyJames B Wetmore, Jiannong Liu, Thy P Do, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
Coronary and aortic calcifications in patients new to dialysisDavid M Spiegel, Paolo Raggi, Ravindra Mehta, et al.
Pageof 12